Cargando…
Evolution of combined impaired fasting glucose and impaired glucose tolerance in β-thalassemia major: Results in 58 patients with a mean 7.7- year follow-up
BACKGROUND: Advances in β- thalassemia major (β-TM) care have transformed a disease which had previously led to an early childhood death into a chronic condition. With increased lifespan, comorbidities associated with the disease have become more common, among them glucose dysregulation (GD) which d...
Autores principales: | De Sanctis, Vincenzo, Daar, Shahina, Soliman, Ashraf T, Tzoulis, Ploutarchos, Yassin, Mohamed A., Kattamis, Christos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mattioli 1885
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9335433/ https://www.ncbi.nlm.nih.gov/pubmed/35775758 http://dx.doi.org/10.23750/abm.v93i3.12825 |
Ejemplares similares
-
The effects of excess weight on glucose homeostasis in young adult females with β-thalassemia major (β-TM): A preliminary retrospective study
por: De Sanctis, Vincenzo, et al.
Publicado: (2023) -
Pancreatic changes affecting glucose homeostasis in transfusion dependent β-thalassemia (TDT): a short review
por: de Sanctis, Vincenzo, et al.
Publicado: (2021) -
Insulin-like growth factor -1 (IGF-1) and glucose dysregulation in young adult patients with β-thalassemia major: causality or potential link?
por: De Sanctis, Vincenzo, et al.
Publicado: (2022) -
A study of isolated hyperglycemia (blood glucose ≥155 mg/dL) at 1-hour of oral glucose tolerance test (OGTT) in patients with β-transfusion dependent thalassemia (β-TDT) followed for 12 years
por: de Sanctis, Vincenzo, et al.
Publicado: (2021) -
Screening for glucose dysregulation in β-thalassemia major (β-TM): An update of current evidences and personal experience
por: De Sanctis, Vincenzo, et al.
Publicado: (2022)